Alf Meem Yaa for Medical Supplies and Equipment (TADAWUL:9527) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Alf Meem Yaa for Medical Supplies and Equipment Company (TADAWUL:9527) announced strong profits, but the stock was stagnant. Our analysis suggests that this might be because shareholders have noticed some concerning underlying factors.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

Examining Cashflow Against Alf Meem Yaa for Medical Supplies and Equipment's Earnings

As finance nerds would already know, the accrual ratio from cashflow is a key measure for assessing how well a company's free cash flow (FCF) matches its profit. The accrual ratio subtracts the FCF from the profit for a given period, and divides the result by the average operating assets of the company over that time. The ratio shows us how much a company's profit exceeds its FCF.

That means a negative accrual ratio is a good thing, because it shows that the company is bringing in more free cash flow than its profit would suggest. While having an accrual ratio above zero is of little concern, we do think it's worth noting when a company has a relatively high accrual ratio. That's because some academic studies have suggested that high accruals ratios tend to lead to lower profit or less profit growth.

Alf Meem Yaa for Medical Supplies and Equipment has an accrual ratio of 0.45 for the year to December 2024. As a general rule, that bodes poorly for future profitability. And indeed, during the period the company didn't produce any free cash flow whatsoever. In the last twelve months it actually had negative free cash flow, with an outflow of ر.س4.1m despite its profit of ر.س45.4m, mentioned above. It's worth noting that Alf Meem Yaa for Medical Supplies and Equipment generated positive FCF of ر.س35m a year ago, so at least they've done it in the past. The good news for shareholders is that Alf Meem Yaa for Medical Supplies and Equipment's accrual ratio was much better last year, so this year's poor reading might simply be a case of a short term mismatch between profit and FCF. Shareholders should look for improved cashflow relative to profit in the current year, if that is indeed the case.

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Alf Meem Yaa for Medical Supplies and Equipment .

Our Take On Alf Meem Yaa for Medical Supplies and Equipment's Profit Performance

As we discussed above, we think Alf Meem Yaa for Medical Supplies and Equipment's earnings were not supported by free cash flow, which might concern some investors. As a result, we think it may well be the case that Alf Meem Yaa for Medical Supplies and Equipment's underlying earnings power is lower than its statutory profit. But on the bright side, its earnings per share have grown at an extremely impressive rate over the last three years. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. If you want to do dive deeper into Alf Meem Yaa for Medical Supplies and Equipment, you'd also look into what risks it is currently facing. For example, Alf Meem Yaa for Medical Supplies and Equipment has 2 warning signs (and 1 which is potentially serious) we think you should know about.

Today we've zoomed in on a single data point to better understand the nature of Alf Meem Yaa for Medical Supplies and Equipment's profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.